# New Conditions Eligible For Medicinal Cannabis | The Journal-News > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/new-conditions-eligible-for-medicinal-cannabis-the-journal-news/ > **Published:** 2026-09-08T07:12:33-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:45:14-04:00 > **Clinical Summary:** Explore the newly added conditions eligible for medicinal cannabis treatment and how this impacts clinical practice. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SleepAnxietyNeurologyPolicyMental HealthResearchSafety Why This Matters This article matters for clinicians and their patients as it expands the list of qualifying conditions for medicinal cannabis use, potentially offering relief to more patients suffering from these conditions. Understanding the new eligibility criteria is crucial for healthcare providers to make informed decisions about treatment options. The inclusion of additional conditions may lead to improved patient outcomes in managing symptoms and overall quality of life. Clinical Summary In “New Conditions Eligible for Medicinal Cannabis,” The Journal-News reports that two new conditions have been approved for treatment with medical cannabis. These conditions expand the eligibility criteria for patients seeking medicinal cannabis therapy. The practical takeaway for clinicians and patients is an increased availability of medicinal cannabis options for managing a broader range of health conditions. Dr. Caplan’s Take “As a seasoned family physician specializing in cannabis medicine, the expansion of eligible conditions for medicinal cannabis treatment is noteworthy. However, it’s crucial to emphasize that while these additions show promising potential, further clinical research and long-term studies are necessary to fully understand their efficacy and safety.” Clinical Perspective 🔬 In the latest development, “New Conditions Eligible For Medicinal Cannabis” (The Journal-News) expands the scope of qualifying conditions for medical marijuana treatment. The addition of these new conditions broadens therapeutic options for patients suffering from these specific ailments. However, it’s crucial to acknowledge that the efficacy and safety of cannabis in treating these conditions remain complex due to varying responses among patients and potential interactions with other medications. As healthcare providers, we must stay informed about the latest research and guidelines to ensure we provide evidence-based recommendations tailored to each patient’s unique needs. Practically speaking, this expansion underscores the need for ongoing dialogue between clinicians, patients, and policymakers to optimize the use of medicinal cannabis in clinical practice. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20New%20Conditions%20Eligible%20For%20Medicinal%20Cannabis%20%7C%20The%20Journal-News%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90918)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90918)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20New%20Conditions%20Eligible%20For%20Medicinal%20Cannabis%20%7C%20The%20Journal-News%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90918)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [CED Digest: 230 Items — March 18, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) - [CED Digest: 230 Items — March 17, 2026](https://cedclinic.com/cannabis-clinical-research-digest-march-2026/) - [CED Digest: 230 Items — March 15, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-clinical-relevance-2026/) 📰 Source: [http://www.thejournal-news.net/stories/new-conditions-eligible-for-medicinal-cannabis,245595?](http://www.thejournal-news.net/stories/new-conditions-eligible-for-medicinal-cannabis,245595?) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).